Literature DB >> 25328942

Pembrolizumab for treatment of refractory melanoma.

Sanjeet Bagcchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25328942     DOI: 10.1016/s1470-2045(14)70348-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  13 in total

1.  Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.

Authors:  Harriet M Kluger; Christopher R Zito; Meaghan L Barr; Marina K Baine; Veronica L S Chiang; Mario Sznol; David L Rimm; Lieping Chen; Lucia B Jilaveanu
Journal:  Clin Cancer Res       Date:  2015-03-18       Impact factor: 12.531

2.  18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start.

Authors:  Ferdinand Seith; Andrea Forschner; Holger Schmidt; Christina Pfannenberg; Brigitte Gückel; Konstantin Nikolaou; Christian la Fougère; Claus Garbe; Nina Schwenzer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-22       Impact factor: 9.236

Review 3.  Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.

Authors:  Aitziber Buqué; Norma Bloy; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Aurélien Marabelle; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

4.  Immuno-Oncology: The Third Paradigm in Early Drug Development.

Authors:  Juan Martin-Liberal; Cinta Hierro; Maria Ochoa de Olza; Jordi Rodon
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

5.  Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation.

Authors:  Zachary Davis; Martin Felices; Todd Lenvik; Sujan Badal; Joshua T Walker; Peter Hinderlie; James L Riley; Daniel A Vallera; Bruce R Blazar; Jeffrey S Miller
Journal:  Blood Adv       Date:  2021-02-23

Review 6.  Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review.

Authors:  Roberta Balansin Rigon; Márcia Helena Oyafuso; Andressa Terumi Fujimura; Maíra Lima Gonçalez; Alice Haddad do Prado; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

Review 7.  Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy.

Authors:  Anna Niezgoda; Piotr Niezgoda; Rafał Czajkowski
Journal:  Biomed Res Int       Date:  2015-06-10       Impact factor: 3.411

Review 8.  Classification of current anticancer immunotherapies.

Authors:  Lorenzo Galluzzi; Erika Vacchelli; José-Manuel Bravo-San Pedro; Aitziber Buqué; Laura Senovilla; Elisa Elena Baracco; Norma Bloy; Francesca Castoldi; Jean-Pierre Abastado; Patrizia Agostinis; Ron N Apte; Fernando Aranda; Maha Ayyoub; Philipp Beckhove; Jean-Yves Blay; Laura Bracci; Anne Caignard; Chiara Castelli; Federica Cavallo; Estaban Celis; Vincenzo Cerundolo; Aled Clayton; Mario P Colombo; Lisa Coussens; Madhav V Dhodapkar; Alexander M Eggermont; Douglas T Fearon; Wolf H Fridman; Jitka Fučíková; Dmitry I Gabrilovich; Jérôme Galon; Abhishek Garg; François Ghiringhelli; Giuseppe Giaccone; Eli Gilboa; Sacha Gnjatic; Axel Hoos; Anne Hosmalin; Dirk Jäger; Pawel Kalinski; Klas Kärre; Oliver Kepp; Rolf Kiessling; John M Kirkwood; Eva Klein; Alexander Knuth; Claire E Lewis; Roland Liblau; Michael T Lotze; Enrico Lugli; Jean-Pierre Mach; Fabrizio Mattei; Domenico Mavilio; Ignacio Melero; Cornelis J Melief; Elizabeth A Mittendorf; Lorenzo Moretta; Adekunke Odunsi; Hideho Okada; Anna Karolina Palucka; Marcus E Peter; Kenneth J Pienta; Angel Porgador; George C Prendergast; Gabriel A Rabinovich; Nicholas P Restifo; Naiyer Rizvi; Catherine Sautès-Fridman; Hans Schreiber; Barbara Seliger; Hiroshi Shiku; Bruno Silva-Santos; Mark J Smyth; Daniel E Speiser; Radek Spisek; Pramod K Srivastava; James E Talmadge; Eric Tartour; Sjoerd H Van Der Burg; Benoît J Van Den Eynde; Richard Vile; Hermann Wagner; Jeffrey S Weber; Theresa L Whiteside; Jedd D Wolchok; Laurence Zitvogel; Weiping Zou; Guido Kroemer
Journal:  Oncotarget       Date:  2014-12-30

Review 9.  A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints.

Authors:  Yongshu Li; Fangfei Li; Feng Jiang; Xiaoqing Lv; Rongjiang Zhang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-07-18       Impact factor: 5.923

Review 10.  The Promise of Preventive Cancer Vaccines.

Authors:  Pier-Luigi Lollini; Federica Cavallo; Patrizia Nanni; Elena Quaglino
Journal:  Vaccines (Basel)       Date:  2015-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.